News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–122
Matches
122
Sources here
7
Companies here
2
Search results Stored financial headlines

Active search

122 matching headlines

Ticker or company: 2028Main company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

B. Riley raises AST SpaceMobile to Buy rating, citing valuation opportunity after stock's sharp pullback from May highs

B. Riley upgraded AST SpaceMobile (ASTS) to Buy from Neutral, maintaining an $85 price target, despite a 44% decline in shares over six months. The upgrade follows AST SpaceMobile's $1 billion convertible senior notes offering, which analyst Mike Crawford believes provides sufficient capital for …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Rubico Terminates $30 Million Equity Facility With B. Riley

Rubicon Technologies terminated its $30 million equity line of credit with B. Riley Principal Capital, citing the facility's misalignment with its current capital plan and an advantageous market position for future financing. The company plans to continue pursuing non-dilutive and strategic financing alternatives.

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

B. Riley Financial Issues Positive Forecast for Trevi Therapeutics (NASDAQ:TRVI) Stock Price

B. Riley Financial has increased its price target for Trevi Therapeutics (NASDAQ:TRVI) to $31 from $21, maintaining a "buy" rating and suggesting a 64% upside. While other analysts have a "Moderate Buy" consensus with an average target of $23.80, Weiss Ratings reiterated a "sell" …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TRVI Maintains Buy by B. Riley Securities -- Price Target Raised to $31.00

B. Riley Securities has maintained a Buy rating for Trevi Therapeutics (TRVI) and increased its price target to $31.00 from $21.00, signaling strong confidence in the company's potential, especially for its Haduvio therapy. Despite this bullish analyst outlook, Trevi Therapeutics faces financial challenges with …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

B. Riley keeps Hut 8 at Buy after second $9.8 billion Beacon Point lease

B. Riley Securities has maintained its Buy rating and $130 price target for Hut 8 after the company signed a second 15-year lease valued at $9.8 billion for 352 MW of IT capacity at its Beacon Point campus in Texas. This triple-net lease for …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ASTS Upgraded by B. Riley Securities -- Rating Raised to Buy

AST SpaceMobile (ASTS) has been upgraded from a "Neutral" to a "Buy" rating by B. Riley Securities, with the price target maintained at $85.00. While GuruFocus indicates the stock is significantly undervalued with a GF Value™ of $488.29 against a current price of $57.80, …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AST SpaceMobile Shares Rise After B. Riley Upgrade

This article reports on AST SpaceMobile (ASTS) shares rising following an upgrade from B. Riley. The upgrade reflects a positive outlook for the company's future prospects.

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CNK Maintained by B. Riley Securities -- Price Target Lowered to $35

B. Riley Securities has maintained a Neutral rating on Cinemark Holdings (CNK) but lowered its price target to $35.00 from $36.00. While GuruFocus suggests the stock is undervalued by 4.8% at $30.27, mixed analyst sentiment and recent insider selling of $4.4 million warrant caution …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AST SpaceMobile surges as B. Riley raises on valuation after selloff (ASTS:NASDAQ)

AST SpaceMobile (ASTS) saw its stock rise by 7.8% on Friday after B. Riley upgraded the company's rating to Buy from Neutral, setting an $85 price target. This upgrade follows a 44% slump in the shares over the past six months, with B. Riley …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cinemark (NYSE:CNK) Price Target Cut to $35.00 by Analysts at B. Riley Financial

B. Riley Financial has reduced its price target for Cinemark (NYSE:CNK) to $35.00 from $36.00, maintaining a "neutral" rating, which implies a potential 15% upside. This adjustment comes amidst mixed analyst sentiment, with Goldman Sachs upgrading the stock to neutral and Zacks downgrading it …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

B.Riley upgrades AST Spacemobile stock rating to Buy on funding

B.Riley upgraded AST Spacemobile (NASDAQ:ASTS) from Neutral to Buy, maintaining a price target of $85.00, following the company's successful pricing of $1 billion in convertible senior notes. Despite a 44% decline in share price since a previous downgrade, the company's strong liquidity and progress …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

B.Riley cuts Bitmine Immersion stock price target on staking miss

B.Riley has lowered its price target for Bitmine Immersion Technologies (OTC:BMNR) stock from $33 to $25, while maintaining a Buy rating, following the company's fiscal third-quarter 2026 results which saw staking revenue miss estimates. The shortfall was attributed to the pace of Ethereum staking …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

B. Riley Lifts PT on Angel Studios (ANGX) – Here’s Why

B. Riley has increased its price target for Angel Studios (ANGX) to $8 from $7, maintaining a Buy rating. This adjustment is based on higher near-term estimates, including increased fiscal Q2 paying Guild members and the anticipated positive impact of the upcoming film "Young …

RILYZ main company
Sharemaestro market context Trend signal active 52 weeks +73.1% RILYZ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context